Display options
Cite
Abbasnezhad A, Niazmand S, Mahmoudabady M, et al. Nigella sativa seed decreases endothelial dysfunction in streptozotocin-induced diabetic rat aorta. Avicenna J Phytomed. 2016;6(1):67-76
Abbasnezhad, A., Niazmand, S., Mahmoudabady, M., Soukhtanloo, M., Rezaee, S. A., & Mousavi, S. M. (2016). Nigella sativa seed decreases endothelial dysfunction in streptozotocin-induced diabetic rat aorta. Avicenna journal of phytomedicine, 6(1), 67-76.
Abbasnezhad, Abbasali, et al. "Nigella sativa seed decreases endothelial dysfunction in streptozotocin-induced diabetic rat aorta." Avicenna journal of phytomedicine vol. 6,1 (2016): 67-76.
Abbasnezhad A, Niazmand S, Mahmoudabady M, Soukhtanloo M, Rezaee SA, Mousavi SM. Nigella sativa seed decreases endothelial dysfunction in streptozotocin-induced diabetic rat aorta. Avicenna J Phytomed. 2016 Jan-Feb;6(1):67-76. PMID: 27247923; PMCID: PMC4884219.
Copy Download .nbib Format: NLM
Share it on

Avicenna J Phytomed. 2016 Jan-Feb;6(1):67-76.

Nigella sativa seed decreases endothelial dysfunction in streptozotocin-induced diabetic rat aorta.

Avicenna journal of phytomedicine

Abbasali Abbasnezhad, Saeed Niazmand, Maryam Mahmoudabady, Mohammad Soukhtanloo, Seyed Abdolrahim Rezaee, Seyed Mojtaba Mousavi

Affiliations

  1. Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  2. Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran ; Cardiovascular Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  3. Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran ; Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  4. Department of Biochemistry, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  5. Department of Immunology , School of Medicine , Mashhad University of Medical Sciences, Mashhad, Iran.

PMID: 27247923 PMCID: PMC4884219

Abstract

OBJECTIVE: Diabetes is an important risk factor for cardiovascular events. The great percent of morbidity in patients with diabetes is due to endothelial dysfunction. The present study investigated the effects of hydroalcholic extract of Nigella sativa (N. sativa) on contractile and dilatation response of isolated aorta in streptozotocin (STZ)-induced diabetic rat.

MATERIALS AND METHODS: Rats were divided into six experimental groups (control, untreated STZ-diabetic, and N. sativa hydroalcholic extract or metformin-treated diabetic rats). Treated rats received N. sativa extract (100, 200, and 400 mg/kg) or metformin (300 mg/kg) by gavage, daily for 6 weeks. Isolated rat thoracic rings were mounted in an organ bath system then contractile and dilatation responses induced by phenylephrine (PE), acetylcholine (ACh), potassium chloride (KCl), and sodium nitroprusside (SNP) were evaluated in different situations.

RESULTS: The lower concentrations of N. sativa seed extract (DE 100 and DE 200) and metformin significantly reduced the contractile responses to higher concentrations of PE (10(-6) - 10(-5) M) compared to diabetic group (p<0.05 to p<0.01). The relaxation response to Ach 10(-8) M, was increased in DE 200 and metformin groups compared to diabetic group (p<0.05). The relaxation responses to Ach 10(-7) - 10(-5) M were significantly higher in all treated groups compared to diabetic group (p<0.05 to p<0.001).

CONCLUSION: Chronic administration of N. sativa seed extract has a significant hypoglycemic effect and improves aortic reactivity to vasoconstrictor and vasodilator agents in STZ-induced diabetic rats.

Keywords: Diabetes mellitus; Endothelial dysfunction; Isolated aorta; Nigella sativa; Rat

References

  1. Pharmacol Rep. 2007 Jul-Aug;59(4):447-55 - PubMed
  2. Asian Pac J Trop Biomed. 2013 May;3(5):337-52 - PubMed
  3. Eur J Pharmacol. 1986 Dec 2;132(1):75-8 - PubMed
  4. Br J Pharmacol. 2010 Dec;161(7):1458-71 - PubMed
  5. Br J Pharmacol. 2000 Jul;130(5):963-74 - PubMed
  6. Circulation. 2009 Sep 29;120(13):1266-86 - PubMed
  7. Br J Pharmacol. 2011 May;163(2):424-37 - PubMed
  8. Endothelium. 2004 Mar-Apr;11(2):89-97 - PubMed
  9. Eur J Pharmacol. 2011 Mar 1;654(1):68-74 - PubMed
  10. Eur J Pharmacol. 2010 Sep 10;642(1-3):113-20 - PubMed
  11. J Pharm Biomed Anal. 1999 Apr;19(5):757-62 - PubMed
  12. Free Radic Biol Med. 2010 Mar 1;48(5):664-72 - PubMed
  13. Evid Based Complement Alternat Med. 2013;2013:120732 - PubMed
  14. Can J Physiol Pharmacol. 2005 Mar;83(3):215-42 - PubMed
  15. Br J Pharmacol. 2010 Apr;159(8):1724-31 - PubMed
  16. J Toxicol. 2015;2015:841823 - PubMed
  17. Eur Heart J. 2013 Aug;34(31):2436-43 - PubMed
  18. Biomed Res Int. 2014;2014:247054 - PubMed
  19. Rev Endocr Metab Disord. 2010 Mar;11(1):61-74 - PubMed
  20. Biochem Soc Trans. 2003 Oct;31(Pt 5):920-4 - PubMed
  21. Phytother Res. 2013 Dec;27(12):1849-53 - PubMed
  22. Lipids Health Dis. 2013 Jun 13;12:86 - PubMed
  23. Life Sci. 2006 Apr 25;78(22):2615-24 - PubMed
  24. Hypertension. 2000 Jan;35(1 Pt 1):108-12 - PubMed
  25. Curr Med Chem. 2009;16(1):94-112 - PubMed
  26. Diab Vasc Dis Res. 2007 Jun;4(2):84-8 - PubMed
  27. Int J Cardiol. 2004 Jan;93(1):19-23 - PubMed
  28. Exp Diabetes Res. 2010;2010:247861 - PubMed
  29. Indian J Exp Biol. 2006 Sep;44(9):745-8 - PubMed
  30. Life Sci. 2005 Oct 7;77(21):2676-89 - PubMed
  31. Circulation. 2003 Sep 30;108(13):1655-61 - PubMed
  32. Lipids Health Dis. 2014 Jul 15;13:115 - PubMed
  33. J Cardiovasc Pharmacol. 1990 Aug;16(2):239-48 - PubMed
  34. Fundam Clin Pharmacol. 2008 Aug;22(4):447-52 - PubMed
  35. Diabetes. 2008 Mar;57(3):696-705 - PubMed
  36. Arq Bras Endocrinol Metabol. 2010 Aug;54(6):530-9 - PubMed

Publication Types